Suppr超能文献

饮食暴露于全氟辛烷磺酸钾会导致 Sprague-Dawley 大鼠肝细胞肥大和细胞增殖,这是由于外源性传感器核受体 PPARα 和 CAR/PXR 的表达增加所致。

Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR.

机构信息

CXR Biosciences Ltd., Dundee DD1 5JJ, Scotland, United Kingdom.

AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG England, United Kingdom.

出版信息

Toxicology. 2012 Mar 11;293(1-3):16-29. doi: 10.1016/j.tox.2011.12.014. Epub 2012 Jan 8.

Abstract

The present study investigated the potential role for activation of PPARα and CAR/PXR by potassium PFOS (K⁺ PFOS) with respect to the etiology of hepatic hypertrophy and hepatocellular adenoma in rats. Male Sprague-Dawley rats were fed K⁺ PFOS (20 or 100 ppm) for either 1, 7, or 28 days. Wyeth 14,643 (Wy 14,643, 50 ppm) and phenobarbital (PB, 500 ppm) were the controls for PPARα and CAR/PXR activation, respectively. Measurements included: plasma ALT, AST, cholesterol, triglycerides, and glucose; liver protein and DNA content; liver activities of palmitoyl CoA oxidase (ACOX), Cyp4A, CYP2B, and CYP3A; induction of liver CYP4A1, CYP2E1, CYP2B1/2, and CYP3A1 proteins (SDS-PAGE and Western blots); liver and thyroid microscopic histopathology, apoptotic index, and cell proliferation index. Terminal body weight was decreased by K⁺ PFOS (100 ppm) and Wy 14,643. All test-compound treatments increased liver weight. Plasma lipids were decreased by both PFOS and Wy 14,643. After treatment for 1 day, K⁺ PFOS (100 ppm), PB, and Wy 14,643 increased mean hepatic DNA concentration and total hepatic DNA, and total DNA remained elevated after treatment for 7 days and 28 days (PB and Wy 14,643 only). Hepatic P450 concentration was elevated after 7 and 28 days by K⁺ PFOS and by PB. K⁺ PFOS and Wy 14,643 increased liver activities of ACOX and CYP4A as well as increased liver CYP4A1 protein. By 28 days of treatment, K⁺ PFOS and PB increased liver activities of CYP2B and CYP3A as well as increased liver CYP2B1/2 and CYP3A1 proteins, and Wy 14,643 increased CYP2B enzyme activity to a slight extent. All test compounds increased the liver cell proliferative index and decreased the liver apoptotic index. No histological changes of the thyroid were noted; however, PB and WY increased thyroid follicular cell proliferation index (seven-day treatment only), while K⁺ PFOS did not. The thyroid follicular cell apoptotic index did not differ between groups. The hepatomegaly and hepatocellular adenoma observed after dietary exposure of Sprague-Dawley rats to K⁺ PFOS likely are due to the increased expression of xenosensor nuclear receptors PPARα and CAR/PXR. Given the markedly lower or absent response of human hepatocytes to the proliferative stimulus from activation of PPARα and CAR/PXR, the hepatocellular proliferative response from activation of these receptors by PFOS observed in rats is not expected to be of human relevance.

摘要

本研究旨在探讨钾全氟辛烷磺酸(K⁺ PFOS)对雄性 Sprague-Dawley 大鼠肝肥大和肝细胞腺瘤发生的潜在作用,及其对过氧化物酶体增殖物激活受体α(PPARα)和细胞色素 P450 受体(CAR/PXR)的激活作用。大鼠分别经口给予 K⁺ PFOS(20 或 100 ppm)1、7 或 28 天,Wy 14,643(50 ppm)和苯巴比妥(PB,500 ppm)分别作为 PPARα 和 CAR/PXR 激活的阳性对照。检测指标包括:血浆丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、胆固醇、甘油三酯和葡萄糖;肝蛋白和 DNA 含量;肝酰基辅酶 A 氧化酶(ACOX)、细胞色素 P4504A(CYP4A)、细胞色素 P4502B(CYP2B)和细胞色素 P4503A(CYP3A)的活性;CYP4A1、CYP2E1、CYP2B1/2 和 CYP3A1 蛋白的诱导(SDS-PAGE 和 Western blot);肝和甲状腺组织病理学检查、凋亡指数和细胞增殖指数。K⁺ PFOS(100 ppm)和 Wy 14,643 降低了大鼠的终末体质量。所有受试化合物均增加了肝重。PFOS 和 Wy 14,643 降低了血浆脂质水平。处理 1 天后,K⁺ PFOS(100 ppm)、PB 和 Wy 14,643 增加了平均肝 DNA 浓度和总肝 DNA,7 天和 28 天处理后总 DNA 仍升高(仅 PB 和 Wy 14,643)。K⁺ PFOS 和 PB 增加了肝 CYP4A 酶活性和 CYP4A1 蛋白水平,7 天和 28 天后肝 P450 浓度升高。K⁺ PFOS 和 Wy 14,643 增加了肝 ACOX 和 CYP4A 酶的活性,并增加了肝 CYP4A1 蛋白水平。28 天处理后,PB 和 Wy 14,643 增加了肝 CYP2B 和 CYP3A 的酶活性,增加了肝 CYP2B1/2 和 CYP3A1 蛋白水平,而 Wy 14,643 轻度增加了 CYP2B 酶活性。所有受试化合物均增加了肝细胞增殖指数,降低了肝凋亡指数。甲状腺组织学无变化;然而,PB 和 Wy 14,643 增加了甲状腺滤泡细胞增殖指数(仅 7 天处理),而 K⁺ PFOS 则没有。各组间甲状腺滤泡细胞凋亡指数无差异。K⁺ PFOS 饮食暴露诱导的 Sprague-Dawley 大鼠肝肿大和肝细胞腺瘤可能是由于过氧化物酶体增殖物激活受体α(PPARα)和细胞色素 P450 受体(CAR/PXR)的表达增加所致。鉴于人类肝细胞对 PPARα 和 CAR/PXR 激活的增殖刺激的反应明显较低或不存在,因此在大鼠中观察到 PFOS 对这些受体的激活导致的肝细胞增殖反应不太可能与人类有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验